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PreviewsA Global View of Metabolites
Fungi are rich sources of medically useful, as well as
toxic, secondary metabolites. In this issue of Chemis-
try & Biology, Bok et al. [1] show that, in Aspergillus
nidulans, microarray analysis and manipulation of a
global regulator can identify novel metabolite genes.
Fungi are well known for their vast diversity of secondary
metabolites [2], including important antibiotics, such as
penicillin produced by Penicillium and Aspergillus spe-
cies, and dangerous toxins, such as aflatoxins produced
by Aspergillus flavus and A. parasiticus. Some second-
ary metabolites produced by human pathogens, such
as melanin in Aspergillus fumigatus, are important for
parasitism [3]. Likewise, many plant pathogenic fungi,
such as the southern corn leaf blight agent Cochliobolus
heterostrophus, produce toxins that are responsible for
the major disease symptoms [4]. Indole alkaloids pro-
duced by the ergot fungus (Claviceps purpurea) are
among the most potent neurotropic agents known and
can cause psychosis and death in humans and live-
stock, whereas the aflatoxins, the most carcinogenic
of metabolites, pose considerable long-term danger to
humans [2]. These natural products represent broad
structural and biosynthetic diversity, including terpe-
noids, polyketides, peptides, and alkaloids. Synthesis
of these metabolites is typically regulated, probably to
ensure that the energy and nutrients used in their syn-
thesis are expended only in the environments where
the metabolites are beneficial.
Identification of genes involved in producing second-
ary metabolites is important for several reasons. En-
zymes for their biosynthesis can give us information on
the mechanisms of metabolic transformations, which
can be used in turn to direct synthesis of new and useful
metabolites [5]. Also, once key toxins in human, plant, or
animal disease are identified, their modes and sites of
action can be elucidated, enabling more informed or di-
rected therapy. Furthermore, discovery of new anti-
biotics, antiviral compounds, anticancer compounds,
and so forth, and their development into pharmaceuti-
cals, can be facilitated by such knowledge [6]. Impor-
tantly, once the gene for one biosynthetic step has
been identified in the fungal genome, adjacent genes
are likely to encode other enzymes of the same pathway
[7]. Thus, the tendency of fungi to cluster genes for
a common pathway helps considerably in gene discov-
ery, although identifying that first gene can be very labo-
rious. Available genome sequences should afford more
facile means to identify novel secondary metabolism
gene clusters and, ultimately, novel metabolites.
Some transcriptional regulator genes have been asso-
ciated with biosynthesis genes and act specifically on
individual pathways, whereas other more global regula-
tors may coordinate secondary metabolism with growth
or developmental stages [2, 8]. In this issue, Bok et al. [1]
manipulate the Aspergillus nidulans gene laeA, a globalregulator of sterigmatocystin (related to aflatoxins),
lovastatin, and penicillin biosynthesis, and observe ef-
fects on previously uncharacterized clusters of genes.
Microarray-based transcriptional profiling of a laeA-
deletion and a laeA-overexpression strain revealed dis-
crete segments of the genome that are subject to laeA
regulation. One such cluster was verified as being in-
volved in secondary metabolism by mutation of one of
its genes, with the resulting loss of production of the
indole-alkaloid terrequinone A.
Regulation of secondary metabolism is tightly linked
to developmental regulation in Aspergillus species [2].
Therefore, alterations in master regulators have pleio-
tropic effects. The A. nidulans fadA gene product, a Ga
protein, regulates conidiation through its effect on
brlA, and regulates penicillin and sterigmatocystin syn-
thesis through effects on pathway-specific regulators
such as AflR (which controls sterigmatocystin genes),
as well as global regulators such as protein kinase A
(PkaA). The latter suppresses LaeA activity, though it
is unknown whether this is a direct or indirect effect
(there is no indication of a PkaA target site in LaeA) [8].
Interestingly, laeA is regulated by the pathway-specific
regulator AflR, providing feedback that may prevent
overexpression of sterigmatocystin [8].
One model suggests that LaeA may participate in, or
affect, histone methylation, and this might alter the state
of chromatin in metabolite gene clusters [2]. A conver-
sion from a heterochromatic to euchromatic state would
be expected to upregulate the clustered genes. Cur-
rently, this is a speculative hypothesis. The LaeA se-
quence suggests it may bind S-adenosylmethionine,
although conserved domain searches do not give espe-
cially low expect values (personal observation; R6 3
1026 to the signature domain of anO-methyltransferase).
Also, no obvious DNA binding motif is evident in the LaeA
signature, suggesting that it might need to be recruited
to the chromatin by DNA binding proteins. If so, the basis
for LaeA specificity for secondary metabolism gene clus-
ters is not obvious. On the other hand, an N-terminal fu-
sion of LaeA to green fluorescence protein localizes to
nuclei [8], suggesting that its effect on mRNA levels
may be a direct modulation of transcription.
The approach taken by Bok et al. [1] is an elegant uti-
lization of genomic resources in an extraordinarily well-
characterized regulatory system. An interesting ques-
tion now is whether the approach can be extrapolated
beyond Aspergillus species to the myriad other fungi
that are metabolically interesting but for which there is
much less information on gene regulation. In such fungi,
the identification of characteristic biosynthetic genes
may be an easier approach. Most known secondary me-
tabolite gene clusters are characterized by genes for
one or more of four protein families: nonribosomal pep-
tide synthetases, polyketide synthases, terpene cy-
clases, and DmaW-homologous prenyl transferases
[2]. It is noteworthy that the prototypical dmaW, whose
product catalyzes the first step in ergot alkaloid synthe-
sis, was eventually identified after decades of investiga-
tion by several groups, culminating in purification and
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[9], and that once identified its sequence showed no re-
lationship to any other known prenyl transferase. Yet
dmaW homologs are evident in numerous secondary
metabolite clusters, including the newly identified terre-
quinone A cluster [1]. In the future, other previously un-
recognized, but essential and conserved, gene families
might be identified for other metabolite gene clusters.
For example, the loline alkaloid (LOL) gene cluster of
Neotyphodium uncinatum contains ten genes, none of
which fall into the four aforementioned categories [10].
Even so, the relationships of LOL proteins to pyridoxal
phosphate enzymes, monooxygenases, or nonheme-
iron oxygenases strongly suggest that this is a second-
ary metabolism cluster.
Thus, two approaches appear promising for identify-
ing novel secondary metabolism clusters in sequenced
genomes: identification of signature protein families
[2], and demonstration of coordinated regulation with
other metabolite gene clusters [1]. Bok et al. [1] demon-
strate that the latter approach holds considerable prom-
ise for Aspergillus species. The degree to which the
technique can be applied to other fungal groups de-
pends on whether global regulation is typical or atypical
across the kingdom. A promising observation is that ho-
mologs of laeA are apparent in sequenced genomes of
other fungi in the phylum Ascomycota. But, there is
actually an embarrassment of riches. For example, a
BLASTp search of LaeA sequence against the protein
database for Gibberella zeae PH-1—also known for its
secondary metabolites and toxins—brings up 37 hits
with E values ranging from 1 3 10247 to 7 3 10221 (per-
sonal observation). Obviously, these cannot all be global
regulators. Does the top of this list represent the func-
tional homolog of LaeA, or does the next one (at 9.7 3
10246), or do none of them? Follow-up studies of other
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A Tighter RVxF Motif
Makes a Finer Sift
Most partners of protein phosphatase 1 rely on an in-
stance of the so-called RVxF motif for interaction
with the enzyme. In this issue of Chemistry & Biology,
a stringent definition of the motif targeting high-
affinity instances enabled Meiselbach and colleagues
to recognize novel binding partners with high specific-
ity [1].
For a protein, a key to durable protection from mutation
is the acquisition of one or more essential functions that
involve interactions with multiple partners. Few proteinsglobal regulation appears to be typical of diverse fungal
genera, what ecological conditions might they have in
common that would have selected this behavior? If, on
the other hand, other fungi tend not to exhibit global reg-
ulation of secondary metabolism, what are the ecologi-
cal variables that have led to such divergent regulatory
strategies?
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are better placed to illustrate the success of this strategy
than protein phosphatase 1 (PP1), an enzyme that re-
moves phosphoryl moieties from Ser or Thr residues in
proteins [2–5]. Beginning in early eukaryotic evolution,
this enzyme formed interactions with proteins that target
and regulate its activity toward various specific sub-
strates. Some of the earliest of these alliances, presum-
ably including those with the mitotic regulator Sds22 [6]
and the less well characterized Inhibitor-3 [7], became in-
dispensable for eukaryotic survival. The ensuing need
for conservation of the different interaction sites in-
volved has severely constrained further mutation of the
enzyme [2].
However, the structural rigidity of PP1 has not halted
its functional evolution. To the contrary, to meet new
regulatory demands in different eukaryotic lineages, its
